Precipio (PRPO) Competitors $17.74 +1.64 (+10.19%) Closing price 09/5/2025 03:59 PM EasternExtended Trading$18.10 +0.36 (+2.03%) As of 09/5/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock PRPO vs. PRE, INTT, NAUT, OPXS, ODYS, OPTX, AATC, CLIR, DAIO, and MSAIShould you be buying Precipio stock or one of its competitors? The main competitors of Precipio include Prenetics Global (PRE), inTEST (INTT), Nautilus Biotechnology (NAUT), Optex Systems (OPXS), Odysight.ai (ODYS), Syntec Optics (OPTX), Autoscope Technologies (AATC), ClearSign Technologies (CLIR), Data I/O (DAIO), and MultiSensor AI (MSAI). These companies are all part of the "measuring and control equipment" industry. Precipio vs. Its Competitors Prenetics Global inTEST Nautilus Biotechnology Optex Systems Odysight.ai Syntec Optics Autoscope Technologies ClearSign Technologies Data I/O MultiSensor AI Prenetics Global (NASDAQ:PRE) and Precipio (NASDAQ:PRPO) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, earnings, dividends, media sentiment, risk, valuation, institutional ownership and analyst recommendations. Do insiders & institutionals hold more shares of PRE or PRPO? 25.0% of Prenetics Global shares are held by institutional investors. Comparatively, 10.4% of Precipio shares are held by institutional investors. 7.8% of Prenetics Global shares are held by company insiders. Comparatively, 16.9% of Precipio shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Which has higher valuation and earnings, PRE or PRPO? Precipio has lower revenue, but higher earnings than Prenetics Global. Precipio is trading at a lower price-to-earnings ratio than Prenetics Global, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPrenetics Global$30.62M3.43-$46.30M-$3.99-2.03Precipio$21.24M1.35-$4.29M-$1.19-14.91 Is PRE or PRPO more profitable? Precipio has a net margin of -8.48% compared to Prenetics Global's net margin of -115.91%. Precipio's return on equity of -15.00% beat Prenetics Global's return on equity.Company Net Margins Return on Equity Return on Assets Prenetics Global-115.91% -28.07% -22.27% Precipio -8.48%-15.00%-10.21% Does the media refer more to PRE or PRPO? In the previous week, Precipio had 4 more articles in the media than Prenetics Global. MarketBeat recorded 4 mentions for Precipio and 0 mentions for Prenetics Global. Precipio's average media sentiment score of 1.00 beat Prenetics Global's score of 0.68 indicating that Precipio is being referred to more favorably in the news media. Company Overall Sentiment Prenetics Global Positive Precipio Positive Do analysts recommend PRE or PRPO? Prenetics Global currently has a consensus price target of $9.00, suggesting a potential upside of 11.25%. Given Prenetics Global's stronger consensus rating and higher possible upside, equities research analysts plainly believe Prenetics Global is more favorable than Precipio.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Prenetics Global 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Precipio 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has more volatility and risk, PRE or PRPO? Prenetics Global has a beta of 0.15, meaning that its share price is 85% less volatile than the S&P 500. Comparatively, Precipio has a beta of 1.09, meaning that its share price is 9% more volatile than the S&P 500. SummaryPrecipio beats Prenetics Global on 9 of the 16 factors compared between the two stocks. Get Precipio News Delivered to You Automatically Sign up to receive the latest news and ratings for PRPO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PRPO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PRPO vs. The Competition Export to ExcelMetricPrecipioMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$26.08M$2.09B$5.77B$9.91BDividend YieldN/AN/A6.71%4.52%P/E Ratio-14.9138.2075.5426.08Price / Sales1.359.34480.4288.30Price / CashN/A52.8536.9659.01Price / Book2.1711.1511.446.09Net Income-$4.29M-$63.67M$3.28B$266.14M7 Day Performance15.27%-1.25%0.96%0.44%1 Month Performance22.73%6.08%7.83%4.55%1 Year Performance186.59%37.17%62.64%26.15% Precipio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PRPOPrecipio0.9643 of 5 stars$17.74+10.2%N/A+181.6%$26.08M$21.24M-14.9160Short Interest ↓High Trading VolumePREPrenetics Global1.3291 of 5 stars$7.61+2.8%$9.00+18.3%+79.0%$98.88M$30.62M-1.911INTTinTEST3.601 of 5 stars$7.00-2.5%$12.00+71.4%+10.7%$87.35M$121.64M30.44320NAUTNautilus Biotechnology2.8336 of 5 stars$0.68-1.0%$2.13+212.5%-74.3%$85.89MN/A-1.31130News CoverageGap UpOPXSOptex Systems1.4887 of 5 stars$10.99+0.4%N/A+49.9%$75.98M$33.99M14.6580Positive NewsShort Interest ↑ODYSOdysight.ai1.0108 of 5 stars$3.93+3.1%$10.00+154.5%N/A$64.18M$3.96M-3.7140News CoverageOPTXSyntec Optics0.9971 of 5 stars$1.60-1.2%N/A+26.1%$58.70M$29.44M0.003News CoverageUpcoming EarningsShort Interest ↓AATCAutoscope TechnologiesN/A$7.30+0.6%N/A-0.8%$40.08M$12.89M8.3040CLIRClearSign Technologies1.7283 of 5 stars$0.58-1.5%$2.00+242.3%-14.7%$30.63M$3.60M-5.3110Gap UpDAIOData I/O1.49 of 5 stars$3.10-0.3%$5.22+68.4%+34.9%$29.10M$21.77M-11.07100News CoverageShort Interest ↑MSAIMultiSensor AI2.8027 of 5 stars$0.68-6.5%$2.50+269.1%-69.6%$23.42M$7.40M0.0035 Related Companies and Tools Related Companies Prenetics Global Alternatives inTEST Alternatives Nautilus Biotechnology Alternatives Optex Systems Alternatives Odysight.ai Alternatives Syntec Optics Alternatives Autoscope Technologies Alternatives ClearSign Technologies Alternatives Data I/O Alternatives MultiSensor AI Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PRPO) was last updated on 9/6/2025 by MarketBeat.com Staff From Our Partners6-Figure Target for BTC by 2025Crypto ETF records broken – here's what’s next The biggest names in finance have built the infrastructure f...Crypto 101 Media | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredWarren Buffett's Strangest AI InvestmentTrump Schedules Controversial 'Market Reset' for September 30 Behind closed doors, the White House has orde...Altimetry | SponsoredTrump’s national nightmare is hereThe headlines are shocking: Washington has taken a $10 billion stake in one of America’s biggest chipmakers — ...Porter & Company | SponsoredOdd trade could help investors secure their wealth in 2025The most profitable phrase you’ve never heard of... Have you heard of 310F? This simple string of code coul...Eagle Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Precipio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Precipio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
